Pharmacological Studies with Cefamandole in Human Volunteers
Overview
Authors
Affiliations
Serum and urine concentrations were measured after administration of 0.5-and 1-g doses of cefamandole intramuscularly and intravenously to healthy volunteers. Intramuscular doses of 0.5 and 1 g yielded serum concentrations at 1 h of 14.7 and 35.6 mug/ml, respectively. Significant antibacterial concentrations persisted through h 8. Intravenous doses of 0.5 and 1 g resulted in respective peak serum levels of 21 mug/ml at 45 min and 103 mug/ml at 15 min; these serum levels rapidly declined. Very high urine concentrations were achieved during the first 8 h after injection.
SNYDER N, Tabas L, Berry D, Duckworth D, Spry D, Dantzig A Antimicrob Agents Chemother. 1997; 41(8):1649-57.
PMID: 9257735 PMC: 163979. DOI: 10.1128/AAC.41.8.1649.
Pharmacokinetics of cefamandole in osseous tissue.
Lunke R, Fitzgerald Jr R, Washington 2nd J Antimicrob Agents Chemother. 1981; 19(5):851-8.
PMID: 7294769 PMC: 181534. DOI: 10.1128/AAC.19.5.851.
Evaluation of cefamandole susceptibility testing of Enterobacteriacea by the autobac 1 system.
De Girolami P, Maher L, Booth M, St George D J Clin Microbiol. 1980; 12(4):546-9.
PMID: 6999021 PMC: 273633. DOI: 10.1128/jcm.12.4.546-549.1980.
The influence of uremia on the accessibility of phosphomycin into interstitial tissue fluid.
Fernandez Lastra C, Marino E, Dominguez-Gil A, Tabernero J, Gonzalez Lopez A, Yuste Chaves M Eur J Clin Pharmacol. 1983; 25(3):333-8.
PMID: 6628521 DOI: 10.1007/BF01037944.
Disposition kinetics of cefamandole during continuous ambulatory peritoneal dialysis.
Bliss M, Mayersohn M, Arnold T, Logan J, Michael U, Jones W Antimicrob Agents Chemother. 1986; 29(4):649-53.
PMID: 3707113 PMC: 180460. DOI: 10.1128/AAC.29.4.649.